NEW YORK ( TheStreet) -- Jazz Pharmaceuticals (Nasdaq: JAZZ) hit a new 52-week high Monday as it is currently trading at $47.98, above its previous 52-week high of $47.88 with 878,073 shares traded as of 1:25 p.m. ET. Average volume has been 716,000 shares over the past 30 days. Jazz has a market cap of $1.75 billion and is part of the health care sector and drugs industry. Shares are up 17.5% year to date as of the close of trading on Friday. Jazz Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the identification, development, and commercialization of pharmaceutical products to meet unmet medical needs. The company has a P/E ratio of 16.7, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter